Neurocrine extends former CMO Eiry Roberts as Strategic Advisor through Dec 31, 2026

NEUROCRINE BIOSCIENCES INC

Roberts, former CMO, transitioned to Strategic Advisor effective June 2, 2025; term extended to Dec 31, 2026 (Amended Employment Agreement).
Base salary of $731,400 through Dec 31, 2025; future salary to be set by Compensation Committee thereafter.
Annual cash incentive bonus target 60% of base pay for 2025 and 2026, subject to corporate and individual goals.
Employment agreement expires Dec 31, 2026 unless earlier terminated; no severance upon natural expiration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.